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Abstract
Case reports of patients with mal-functioning metal-on-metal hip replacement (MoMHR) prostheses suggest an association
of elevated circulating metal levels with visual and auditory dysfunction. However, it is unknown if this is a cumulative
exposure effect and the impact of prolonged low level exposure, relevant to the majority of patients with a well-functioning
prosthesis, has not been studied. Twenty four male patients with a well-functioning MoMHR and an age and time since
surgery matched group of 24 male patients with conventional total hip arthroplasty (THA) underwent clinical and
electrophysiological assessment of their visual and auditory health at a mean of ten years after surgery. Median circulating
cobalt and chromium concentrations were higher in patients after MoMHR versus those with THA (P,0.0001), but were
within the Medicines and Healthcare Products Regulatory Agency (UK) investigation threshold. Subjective auditory tests
including pure tone audiometric and speech discrimination findings were similar between groups (P.0.05). Objective
assessments, including amplitude and signal-to-noise ratio of transient evoked and distortion product oto-acoustic
emissions (TEOAE and DPOAE, respectively), were similar for all the frequencies tested (P.0.05). Auditory brainstem
responses (ABR) and cortical evoked response audiometry (ACR) were also similar between groups (P.0.05).
Ophthalmological evaluations, including self-reported visual function by visual functioning questionnaire, as well as
binocular low contrast visual acuity and colour vision were similar between groups (P.0.05). Retinal nerve fibre layer
thickness and macular volume measured by optical coherence tomography were also similar between groups (P.0.05). In
the presence of moderately elevated metal levels associated with well-functioning implants, MoMHR exposure does not
associate with clinically demonstrable visual or auditory dysfunction.
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Introduction
More than 500,000 patients in the United States have received
metal-on-metal hip prostheses, including metal-on-metal hip
resurfacing (MoMHR), the majority of whom have well-function-
ing devices [1]. Cobalt and chromium are the principal metals
released by MoMHR [2,3]. Ten-year steady state median blood
cobalt and chromium concentrations in patients with well-
functioning devices are between 1.5 and 2.3 mg/L, but remain
10-fold higher than physiological levels [4,5].
Case reports relating to prosthesis failure commonly include
visual and auditory problems associated with grossly elevated
blood metal concentrations [6,7,8,9,10,11]. Tower et al. described
two cases in which prosthesis failure associated with hearing loss
[10]. Ikeda et al. quantitated hearing loss by pure tone audiometry
and demonstrated hearing thresholds of 52 and 45 dB in the right
and left ears respectively (average over 0.5, 1, 2 and 4 kHz, normal
,25) [11]. The patient described by Rizzetti et al. had bilateral
absence of brainstem acoustic responses [8]. Assessment of visual
loss within the case studies showed in one case undefined visual
changes and hyper-intensity of the optic nerves and tracts on
magnetic resonance imaging (MRI), and ‘irregular’ cortical visual
responses when measuring visual evoked potentials in another
subject. Whilst these cases highlight association between overt
failure of prosthetic devices and auditory or visual dysfunction, the
effect on these sensory systems of prolonged exposure to
moderately elevated blood metal concentrations, relevant to the
great majority of patients with these devices, has not been defined.
Between 2009 and 2010 we undertook a single-centre cross-
sectional study to investigate the systemic effects of chronic metal
exposure following MoMHR [12]. Thirty-five patients after
MoMHR were individually matched by age, sex and time since
surgery to patients who had received a conventional total hip
arthroplasty (THA) using a non-metal-on-metal bearing at a mean
of 8 years following surgery. Patients within both groups were in
good self-reported health and had well-functioning prostheses. We
identified differences in grey matter density in the occipital cortex
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and in the cross-sectional area of the optic chiasm in subjects
receiving MoMHR versus those who had received a conventional
THA, indicating an association between MoMHR exposure and
subtle structural changes in the visual system of the brain [13].
Following these findings we recalled all 62 male participants in the
study order to conduct a detailed auditory and visual assessment to
determine whether chronic low elevated metal exposure in well-
functioning MoMHR associates with demonstrable functional
effects on these systems.
Patients and Methods
Ethics, design, setting, and participants
This extension study was approved by South Yorkshire
Research Ethics Committee, and all patients provided written
informed consent prior to participation. This single centre study
was undertaken as an extension of a cross sectional study
Investigation examining the systemic effects of metal exposure in
MoMHR. In this extension study all men (n = 31 MoMHR and 31
age-matched THA patients) were invited to return for further
visual and auditory assessment. Patients were recruited from the
community between November 24th, 2009 and May 20th, 2010.
The study design was reviewed by a statistician at Sheffield
Clinical Trials Research Unit, and its conduct and dissemination
of results were reviewed by Sheffield Lay Advisory Panel for Bone
Research. The study inclusion and exclusion criteria are docu-
mented elsewhere [12]. Blood and plasma cobalt and chromium
were measured by inductively-coupled plasma-mass spectroscopy
(ICP-MS), as described previously [12]. Briefly, blood samples
were collected via plastic cannulae using the last draw method
directly into trace element collection tubes, and metal assays were
performed by a laboratory that participates in national trace
element measurement quality assurance schemes (TEQAS).
Auditory Outcomes
Clinical evaluation. All subjects were questioned about their
auditory health including occupational noise exposure, tympanic
membrane perforation, tinnitus and current respiratory infections.
Otoscopic examination was performed by an otolaryngologist to
determine the presence of any co-existent pathology. All Audio-
metric assessments were made in sound attenuated test rooms.
Subjective audiometric tests. Pure tone audiometry (PTA)
was performed in accordance with the British Society of Audiology
recommended procedures (The British Society of Audiology,
2011) using an Aurical Audiometer type 1081 and its associated
OTO suite application software module v. 4.50.01 (GN Oto-
metrics A/S). Air conduction (AC) thresholds were obtained using
TDH39 headphones across the frequency range 0.25 to 8 kHz. If
AC thresholds were raised above 20 dB hearing level (dBHL) then
bone conduction thresholds were measured using a B-71 bone
oscillator across frequencies 0.5 to 4 kHz. The integrated speech
test module was used with the AB word lists and the 50 per cent
speech recognition level measured for each ear [14].
Objective audiometric tests. Evoked oto-acoustic emissions
were recorded to assess cochlear function whilst the electrophys-
iology tests of auditory brainstem response (ABR) and the auditory
cortical response (ACR) were used to assess for retro-cochlear
pathology in the auditory brainstem and auditory cortex
respectively. Both Transient evoked otoacoustic emissions
(TEOAEs) and distortion-product oto-acoustic emissions
(DPOAEs) were recorded using a dual probe DP Echoport
(ILO292-II USB interface) coupled with a laptop using the ILOv6
software (v 6.34.22.0). For the TEOAEs, non-linear type stimuli
with a target level of 84 dB SPL were presented. Noise rejection
threshold was set to 40 dB SPL and 360 sweeps were averaged.
The resulting TEOAEs were analysed over a 2.5 to 20 millisecond
time window and in half octave bands OAE power (1, 1.4, 2, 2.8
and 4 kHz). A response was judged to be present in a given half
octave band if the signal was .25 dBSPL with a signal to noise
ratio .6 dB. For the DPOAEs, two primary tones at frequencies
f1 and f2 were presented at levels L1 and L2= 70 dB SPL with a
fixed frequency ratio of f2/f1 at 1.22.
Oto-neurologic auditory brainstem evoked responses (ABRs)
were recorded using a Biologic Navigator Pro AEP system.
Subjects were asked to relax and if possible go to sleep in a reclined
chair in order to minimise myogenic and movement artifacts.
Alternating polarity 100 ms duration clicks at a repetition rate of
11.1 per second were presented at a stimulus level of 80dBnHL
using TDH-39P headphones. Two channel evoked potential
activity was recorded. Electrodes were placed on the forehead
(common), vertex (jumpered to both channels) and on the left and
right mastoids. EEG activity was sampled over 512 points for a
10.66 ms time epoch (0.5 ms blocking) and amplified with a gain
setting of 150000. Filtering was from 100 to 3000 Hz with an
artefact rejection level of 610 mV peak to peak. A minimum of
two replicated averages each with a minimum of 1800 sweeps were
recorded. The absolute ipsilateral Wave V latency for each ear was
measured along with inter-aural latency differences [15]. A
subjective threshold to the ABR test stimuli was also measured
for each ear.
Auditory cortical evoked responses (ACR) were recorded using
the same Biologic Navigator Pro AEP system and the same
electrode configuration as used for ABR recordings. Subjects were
sat up in a chair and asked to maintain an alert state by reading a
magazine or newspaper. Rarefaction tone burst stimuli calibrated
at 80 dB HL and at a frequency of 1000 Hz (10 cycle linear ramp
and 50 cycle plateau) were presented at a repetition rate of 0.5 per
second using TDH-39P headphones. EEG activity was sampled
over 512 points for a 533 ms time epoch and amplified with a gain
setting of 75000. Filtering was from 1 Hz (12 dB/octave) to 15 Hz
with an artefact rejection level of 645 mV peak to peak. A
minimum of two replicated averages each with a minimum of 40
sweeps were recorded. These replications were further averaged
together to form a grand average and to optimise peak
identification. The P1-N1-P2 sequence was identified and the
amplitudes measured for both ipsilateral and contralateral
recordings. A subjective threshold to the ACR test stimuli was
also measured for each ear.
Visual Outcomes
Clinical evaluation. The ophthalmic evaluation comprised
an ocular and targeted medical history, as well as an ocular
examination made by an Ophthalmologist to exclude primary
ocular pathology. All patients were examined for pupillary defects
and underwent visual field testing to confrontation. Ocular
motility examination, Goldmann applanation tonometry and slit
lamp biomicroscopy were also undertaken. The dilated fundus was
then examined by slit lamp biomicroscopy using 78D and 90D
lenses.
Visual symptoms. The National Eye Institute Visual Func-
tioning Questionnaire (NEI-VFQ) was used to measure self-
reported visual function and general health implications [16]. The
10 question neuro-ophthalmic supplement was administered to
identify visual defects due to neurological disorders [17]. These
were administered before the rest of the evaluation and vision
testing to avoid bias.
Subjective visual tests. Uniocular and binocular best
corrected logMAR visual acuities were measured using Early
Auditory and Visual Health after Hip Resurfacing
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Treatment Diabetic Retinopathy Study (ETDRS) charts at 4 m.
Binocular low contrast acuity was measured using 4 m ETDRS
charts of 1.25% and 2.5% contrast and recorded as logMAR
acuity. Colour vision was assessed binocularly using the Farns-
worth-Munsell 100-hue test (Munsell Color Company, Grand
Rapids, MI, USA) administered under simulated daylight (20 W
Compact fluorescent light of 1152lm and 65,000K colour
temperature) with no time limit imposed. Total error scores were
calculated for each participant using the traditional scoring
method [18]. Partial error scores for the blue-yellow colour axis
and the red-green axis were also calculated for each participant. A
square root transformation was used to normalize the distribution
of error scores for the statistical analyses.
Objective visual tests. Retinal nerve fibre layer thickness
and macular volume were then measured using Spectralis optical
coherence tomography (OCT) (Heidelberg Engineering Ltd,
Heidelberg, Germany). In both eyes, retinal nerve fibre (RNFL)
thickness was measured using the Fast RNFL scanning protocol in
which three circular 3.4 mm diameter scans, centred on the optic
disc were taken, the mean of which was then used to express
RNFL thickness. Macular volume was measured using the Fast
Macular Thickness map protocol, and 6 mm by 6 mm (20u by
20u) of the macular was scanned by means of 25 vertical B scans
centred on the fovea.
Statistical analysis
Between group analyses of PTA were made in each ear
independently, and speech discrimination in the best ear and as
the mean value for both ears. Auditory electrophysiology data was
analysed as the mean value for both ears. OCT measurements
were used for one randomly selected eye from each subject in both
groups unless there was pre-existing ocular disease in one eye,
when the measurement from the fellow unaffected eye was used, as
described by Henderson et al. [19]. Between group analyses of
continuous datasets were made using Students t-test or the Mann-
Whitney test, as appropriate. Categorical data were analysed using
the Chi-squared test. All tests were made 2-tailed with a critical p-
value of 0.05, and made using IBM SPSS statistical software
(version 20, IBM, Portsmouth, UK).
Results
Participants and metal levels
24 participants with MOMHR and 24 with THA agreed to
participate in this extension study. The groups were well matched
for age and time since surgery (Table 1). Median blood, plasma,
and urinary cobalt and chromium were 5 to 10 fold higher in
MoMHR versus THA patients (P,0.0001). However, blood
median and interquartile range metal levels were below guidance
threshold concentration of 7 mg/L suggestive of prosthesis mal-
function, and set by the Medicines and Healthcare Products
Regulatory Agency (MHRA) in the United Kingdom (MDA/
2012/008, 28 February).
Auditory outcomes
Clinical audiological evaluation. The two groups were well
matched based on audiological history findings except self-
reported loud noise exposure, which was greater in the THA
group with 19 cases compared to 11 in the MOMHR group
(Table 2). No patients were excluded from auditory testing
following clinical assessment.
Subjective audiometric tests. The PTA findings were
similar between groups (Figure 1, P.0.05 for all comparisons).
The median half peak levels for speech discrimination in the
subjects best ear were 19 dB (interquartile range 13 to 24) in the
MoMHR subjects versus 17 dB (14 to 20) in the THA subjects
(P = 0.56). The median half peak levels for speech discrimination
expressed as the average of both ears were 21 dB (17 to 26) in the
MoMHR subjects versus 20 dB (16 to 24) in the THA subjects
(P = 1.00).
Objective audiometric tests. The amplitude and signal-to-
noise ratio of the otoacoustic emissions (TEOAE and DPOAE) for
all the frequencies tested were similar between groups (Figure 2,
P.0.05 all comparisons). When considering an emission to be
present when the signal-to-noise-ratio is greater than 6 dB and the
signal greater than 25 dB, the percentage of subjects gaining a
positive test result were also similar. At higher frequencies fewer
emissions were recorded for both groups. Auditory brainstem
responses, expressed as latency time of wave V and the inter-aural
latency differences were similar between the two groups (Table 3,
P.0.05 for both comparisons). No difference was observed
between the ACR parameters measured. The latency times of
N1 and P2 peaks as well as the N1-P2 latency and amplitude were
all similar (Table 3, P.0.05 for all comparisons).
Visual outcomes
Clinical visual evaluation. Unilateral primary ocular dis-
ease was identified in 8 participants. In the MOMHR group there
were 2 subjects with amblyopia and 1 subject with a previous
penetrating eye injury. In the THA group there were two 2
subjects with previous eye trauma, 1 subject with a previous retinal
detachment, 1 subject with amblyopia and 1 subject with severe
macular degeneration. These participants were excluded from the
binocular tests of visual and contrast acuity, Farnsworth-Munsell
Table 1. Patient characteristics.
Characteristic MoMHR (n=24) THA (n=24) P-value
Age at assessment (years) 62.567.1 62?667.5 0.95
Age at time of surgery (years) 52.367.2 52.968.6 0.79
Time since surgery (years) 10.261?8 9.762?5 0.49
*Serum cobalt (mg/L) 0.47 (0.36 to 1.05) 0.06 (0.04 to 0.08) ,0.0001
*Serum chromium (mg/L) 0.61 (0.47 to 2.31) ,0.1 (,0.1 to ,0.1) ,0.0001
*Whole blood cobalt (mg/L) 0.43 (0.29 to 1.26) 0.05 (0.03 to 0.07) ,0.0001
*Whole blood chromium (mg/L) 0.48 (0.33 to 1.82) 0.10 (,0.1 to 0.13) ,0.0001
Data are mean 6SD or median (interquartile range). Analyses are MoMHR versus THA by Student’s t-test or Mann Whitney test.
doi:10.1371/journal.pone.0090838.t001
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100-Hue Test and the NEI-VFQ. For the OCT, which was
performed on individual eyes, only the affected eye was excluded.
Visual symptoms. Patients in both groups had similar
perceived visual functioning quality assessed by the NEI-VFQ
and no evidence of neuro-ophthalmologic dysfunction using the
neuro-ophthalmic supplement (Table 4, P.0.05 for all compar-
isons).
Subjective visual assessments. Both groups had similar
logMAR binocular visual acuity and similar low contrast visual
acuity (at 2.5% and 1.25%) (Table 4, P.0.05 all comparisons).
Table 2. Audiology medical history.
Characteristic MoMHR (n=24) THA (n=24) P-value
Self-reported hearing loss 8 (33%) 10 (42%) 0.77
Previous otalgia 1 (4%) 1 (4%) 1.00
Loud noise exposure 11 (46%) 19 (79%) 0.04
Use of hearing aids 1 (4%) 0 1.00
Current tinnitus 5 (21%) 8 (33%) 0.52
Current balance problems 0 2 (8%) 0.49
Previous tinnitus 8 (33%) 14 (58%) 0.15
Previous balance problems 3 (13%) 3 (13%) 1.00
Ear surgery 0 0 1.00
Previous perforated tympanic membrane 2 (8%) 1 (4%) 1.00
Current ear infection 0 0 1.00
Data are number of patients (percentage). Analyses are MoMHR versus THA by Fisher’s exact test.
doi:10.1371/journal.pone.0090838.t002
Figure 1. Pure Tone Audiogram hearing thresholds in MoMHR
versus THA patients for (top panel) left and (bottom panel)
right ears. Data are mean (95% confidence interval) hearing level
threshold (dB). Analyses are MoMHR versus THA groups by Mann-
Whitney test at each frequency, P.0.05 all comparisons.
doi:10.1371/journal.pone.0090838.g001
Figure 2. Transient Evoked Otoacoustic Emissions (TEOAE, top
panel), Distortion Product Otoacoustic Emissions (DPOAE,
bottom panel). Graphs show mean and standard deviation of the
amplitude recorded for each of the frequencies tested. Analysis
Students T-test, P.0.05 for all.
doi:10.1371/journal.pone.0090838.g002
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Colour discrimination using the Farnsworth-Munsell 100-Hue test
was similar between the two groups (Table 4, P.0.05). Both
groups also showed poorer blue-yellow colour discrimination
ability compared with red-green, consistent with the age-related
decline in colour discrimination (Table 4, P.0.05).
Objective visual assessments. Both RNFL thickness and
macular volume measured by OCT was similar between groups
(Figure 3, P.0.05 for both comparisons).
Discussion
We studied visual and auditory health in patients chronically
exposed to low levels of metal following MoMHR compared with
age matched patients with the same duration of exposure to a
conventional THA. This investigation followed the identification
of structural differences in the brain between these patient groups
[13], and aimed to determine whether these structural differences
associated with quantifiable functional differences between the
groups. Following exclusion of individuals with primary ocular or
aural pathology, patients in both groups had similar auditory and
visual function, as assessed by a range of clinical, subjective, and
objective standardised tests.
This study was conducted in a clinically healthy population of
patients. The MoMHR group is representative of the general
MoMHR population, in that they are typically younger patients
and male, and the majority received the most frequently used
prosthesis brand, the Birmingham Hip Resurfacing (BHR). The
patients also had well-functioning prostheses, representative of the
majority of patients after MoMHR, reflected by good Oxford hip
score and metal levels below the MHRA 7 mg/L threshold.
Case report and occupational exposure evidence suggests that
exposure to high systemic levels of cobalt and chromium may
result in damage to both the visual and auditory systems
Table 3. Auditory responses.
Variable MOMHR (n=24) THA (n=24)
ABR Wave V latency (L-R) (ms) 0 (20.06 to 0.12) 0.08 (20.05 to 0.17)
ABR Wave V latency Mean (ms) 5.77 (5.62 to 5.93) 5.97 (5.74 to 6.09)
CERA N1 Latency (ms) 106.066.0 106.465.4
CERA P2 Latency (ms) 189.5621.6 184.4620.1
CERA N1-P2 latency (ms) 83.5619.0 78.0619.3
CERA N1-P2 amplitude (mV) 11.663.2 10.263.3
Values are mean 6 standard deviation or median (interquartile range). Analyses
are MoMHR versus THA by students t-test or Mann Whitney test; P.0.05, all
comparisons. ABR =Auditory Brainstem Response, CERA=Cortical Evoked
Response Audiometry.
doi:10.1371/journal.pone.0090838.t003
Table 4. Visual function.
Test MOMHR (n=21) THA (n=19)
VFQ: 25 standard questions 98.2 (95.8 to 98.2) 97.4 (94.4 to 98.2)
VFQ: Neuro-ophthalmic supplement 97.5 (87.5 to 100) 97.5 (87.5 to 100)
Binocular visual acuity (LogMar) 20.06 (20.17 to 20.05) 20.08 (20.14 to 0.00)
Contrast visual acuity (LogMar): 2.5% 0.22 (0.20 to 0.33) 0.26 (0.22 to 0.42)
Contrast Visual Acuity (LogMar): 1.25% 0.44 (0.40 to 0.60) 0.42 (0.38 to 0.52)
Color discrimination: Total error score (TES) 52 (40 to 82) 80 (52 to 108)
Color discrimination:
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TES
p
7.5862.29 9.1062.50
Color discrimination: Blue-yellow error score 32 (19 to 56) 39 (27 to 58)
Color discrimination: Red-green error score 27 (19 to 38) 30 (13 to 55)
Values are median (interquartile range). Analysis is MoMHR versus THA by Mann Whitney test; P.0.05, all comparisons. VFQ=Visual Functioning Questionnaire.
doi:10.1371/journal.pone.0090838.t004
Figure 3. Box and whisker plots showing (top panel) difference
in retinal nerve fibre layer thickness, and (bottom panel)
differences in macular volume between the patient groups. All
participants (n = 24) included as either non-pathological eye only or
mean of right and left. All analyses are MOMHR versus THA by
independent t-test (P.0.05 for both comparisons).
doi:10.1371/journal.pone.0090838.g003
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[6,7,8,10,11,20]. Two of the case reports describe high frequency
hearing loss in association with patient reported hearing loss
[10,11]. High frequency hearing loss is a normal feature of ageing
in males (presbycusis), and this characteristic was present to a
similar extent in both our patient groups. The further investigation
of hearing loss by Rizzetti et al showed loss of auditory brainstem
responses bilaterally [8]. Here we performed a much larger scale
study and more detailed assessment and found no evidence of an
association of MoMHR exposure with altered brainstem responses
at metal levels experienced by the majority of patients. The
investigation of individual cases of visual loss with high systemic
metal levels has suggested optic nerve atrophy on funduscopy and
optic nerve and tract hyper-intensity on MRI [8,10]. Using the
principle that damage to the optic nerve and tracts should be
reflected in degeneration of the retinal ganglion cells we
investigated retinal structure using OCT but found no differences
between the groups in our population with well-functioning
prosthesis.
It is important to note the differences between our study
population and those patients described in the case studies. In
contrast to those patients described in the case studies who had
failing prostheses with very high metal levels (up to several
hundred mg/L), our study was designed specifically to determine
whether prolonged exposure to low elevated metal levels is
associated with subtle defects.
Hip resurfacing remains a treatment option in the young male
patient with arthritis. The current FDA advice refers to visual and
auditory problems associated with systemic metal levels and
advises close monitoring of high risk patients (FDA, 2013). Our
data suggest that patients with chronic exposure to lower
concentrations of circulating metal typical of well-functioning
prostheses does not associate with clinically detectable defects in
visual or auditory function. However, it remains unclear whether
such effects may become clinically present with longer-term
exposure.
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